Meet the Bay Area's latest Nobel Prize winner

20 women leading biopharma breakthroughs: gene therapy, record IPOs, pancreatic caner drugs and MASH launches.

In a test of investors' appetite, Lilly-connected TRex Bio plots a $153 million IPO.

Bluesky says the process will still take 18-24 months, so don't expect your new, shortened 'bsky' handle any time soon.

Cancer immunotherapy can lose its punch when tumor-fighting T cells become exhausted, but researchers may have found a way to keep them going longer. Scientists at Memorial Sloan Kettering Cancer Cent...

The kids were asleep in the family home in Stanford, where their father had been speaking in the middle of the night with journalists and well-wishers. Deisseroth, who is 54, shared this year’s medici...

A new single-molecule approach has exposed fleeting stages in viral shell formation that were previously hidden.

Genentech is

What does it really mean to be a Fierce 15 biotech in 2026? This is the question we had to ask ourselves when finalizing this year’s list. With more than 150 high-quality nominees to pick from, the se...

Researchers probe why daraxonrasib tends to stop working after 7 months

Applications of artificial intelligence (AI) in drug discovery have attracted high interest in recent years, but evidence for clinically relevant impact so far is limited. This Perspective discusses p...

When recombinant DNA expert Herbert Boyer, Ph.D., first got a call from venture capitalist Robert Swanson about starting a company, the savvy scientist wasn’t sure a meeting would be worth his time | ...

Drug development requires evidence integration across biological scales and modalities, but relevant tools are fragmented. We introduce the Virtual Biotech, an organization of artificial intelligence ...

Foghorn Therapeutics is laying off 40% | Foghorn Therapeutics is laying off 40% of its workforce after a long-running collaboration with Eli Lilly collapsed over disappointing phase 1 data.

The teams say this method is more accessible and cost efficient

Major discoveries, including the role of DNA, the biological basis of psychology, and the human genome, missed out on science’s top recognition

The deal carries a $1 billion upfront payment and tasks the two companies to develop long-acting antibody drugs that go after the same targets as their blockbuster anti-inflammation agent.

Nearly a century ago, John Maynard Keynes predicted technology would revolutionize how we live and work. To find out what he would think of our current A.I. moment, a Princeton economist brought back ...

Jamie Wyeth makes a pilgrimage to Portland, Maine, to view rare works by Winslow Homer, who has been a potent influence on three generations of Wyeth artists.

Scientists found that five seemingly unrelated conditions, including long Covid, ME/CFS, and PTSD, may disrupt many of the same biological networks involved in immunity, metabolism, and cellular energ...

FDA opens Office of Innovation and Clinical Trial Modernization within CDER, with Marie Bradley as acting director of the Division of Real-World Evidence Analytics.

Found in 70 percent of cancers, the gene is seen as a grand orchestrator but has been surprisingly difficult to stop.

Juan Andres will come out of retirement to rejoin Moderna as COO on Oct. 5, bringing his intimate knowledge of the company as its Merck-partnered cancer vaccine gathers momentum in the clinic.

With prospects for new treatments at an all-time high, researchers are looking for ways to boost survival by treating the disease early.